Skip to main content

Bank of New York Mellon Corp

Bank

Position in NVAX — Novavax Inc

CIK 1390777 NEW YORK, NY

Position in NVAX

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$8,004,340
+$1,648,654 QoQ
Shares Held
849,718
+8.8% QoQ
Ownership
0.515%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 263 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 88% Shared 0% None 12%

Common Shares in NVAX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,844,507,720 across 311 Biotechnology names. NVAX ranks #75 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVAX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,004,340 849,718
2026-03-31 $6,355,686 780,797
2025-12-31 $5,351,261 796,319
2025-09-30 $4,241,752 489,245
2025-06-30 $2,985,556 473,898
2025-03-31 $2,912,907 454,432
2024-12-31 $3,509,064 436,451
2024-09-30 $5,491,357 434,787
2024-06-30 $6,759,704 533,942
2024-03-31 $1,899,905 397,470
2023-12-31 $1,883,702 392,438
2023-09-30 $2,639,209 364,532
2023-06-30 $2,609,459 351,206
2023-03-31 $1,682,697 242,814
2022-12-31 $2,782,547 270,676
2022-09-30 $5,709,120 313,688
2022-06-30 $15,792,094 307,060
2022-03-31 $21,227,547 288,222
2021-12-31 $41,581,291 290,636
2021-09-30 $59,843,343 288,666
2021-06-30 $57,496,518 270,814
2021-03-31 $50,034,668 275,962
2020-12-31 $33,439,059 299,875
2020-09-30 $30,643,870 282,823
2020-06-30 $24,545,239 294,484
2020-03-31 $2,234,506 164,544